healthcare.digital January 10, 2026
Executive Summary
The European healthcare technology (HealthTech) and medical technology (MedTech) landscape enters 2026 at a profound inflection point, characterised by a transition from the speculative fragmentation of the early 2020s to a disciplined era of “industrial maturity.”
Following a period of post-pandemic recalibration in 2024 and a tentative recovery in 2025, the market is poised for a robust, albeit structurally transformed, resurgence in mergers and acquisitions (M&A). The defining theme for the 2026 vintage is “Industrialisation.”
This concept signifies a departure from the fragmented, venture-subsidised experimentation that characterised the 2019–2022 era, moving instead toward scalable, profit-generating platforms that leverage operational leverage, regulatory fortitude, and vertical integration to dominate their respective sub-sectors.
While headline deal values are projected to rise,...







